top of page

CO-DEVELOPMENT PARTNERSHIP

PARTNERS

Companies

Oncoxx and Capitank Pharma consortium

Member of the CAPITANK Pharma consortium

Monoclonal antibodies generation

Oncoxx partner with Roche

Oncoxx partner with Sigma-tau

Oncology, Roche

Rita de Santis, Head Immunology, Sigma-Tau

Oncoxx partner with Kinexus

Diagnostic platform

Oncoxx partner with JN Biosciences LLC

Monoclonal antibodies humanization

Oncoxx partner with Millipore

Antibody licensing to Millipore-Merck USA

Academia

Trop-2 function

Oncoxx and Stanford School of Medicine in Trop-2 function

Oncoxx and Jefferson Kimmel Cancer Center in Trop-2 function

Oncoxx and Erasnus MC in Trop-2 function

Oncoxx and UCL MC in Trop-2 function

Therapy target

Oncoxx and Fondazione IRCCS in Therapy target

Oncoxx and Inserm in Therapy target

Oncoxx and University of California in Therapy target

Oncoxx and University of Milano in Therapy target

Oncoxx and University of Genova in Therapy target

Tumor marker

Oncoxx and Rush University in Tumor marker

Oncoxx and Taurinorum in Tumor marker

Oncoxx and Barensis Univ in Tumor marker

Oncoxx and York University in Tumor marker

Oncoxx and Ferrara University in Tumor marker

Oncoxx and Politecnica Marche University in Tumor marker

Oncoxx and Lille University in Tumor marker

Oncoxx and Pittsburgh University in Tumor marker

Oncoxx and Naples University in Tumor marker

bottom of page